134 results
Page 2 of 7
8-K
EX-99.1
tqd pralr
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
yf6e8p95omwdk8j1qc3
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.1
8ongp6w
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.2
zzlcwtxiyo4 lubhdct
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
u9dc91y2pczoiq7l3ymb
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.2
rkzztqp5vp8
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-2.1
542c48as jh4lwdp0
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-4.1
lme xmxrdz4jmt8
17 Apr 23
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
4:17pm
8-K
EX-99.2
a5zzxfd 5gxru
24 Oct 22
Regulation FD Disclosure
8:46am
S-3ASR
EX-4.7
x7wth
9 Sep 22
Automatic shelf registration
4:31pm
S-3ASR
EX-4.6
mncxan 6i7ko
9 Sep 22
Automatic shelf registration
4:31pm
S-3ASR
EX-4.8
5p7qm6uq7xh32nol
9 Sep 22
Automatic shelf registration
4:31pm
S-3ASR
EX-4.3
b87knhc 8i9rmu13z9p
9 Sep 22
Automatic shelf registration
4:31pm
S-3ASR
rrzk9f1ln1gu60dfu
9 Sep 22
Automatic shelf registration
4:31pm
424B5
dhtv9c1wmzr wezp
10 Aug 22
Prospectus supplement for primary offering
5:07pm